东宝生物
(300239)
| 流通市值：34.27亿 | | | 总市值：34.49亿 |
| 流通股本：5.90亿 | | | 总股本：5.94亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 483,228,383.16 | 520,577,739.7 | 477,954,713.78 | 532,101,881.48 |
| 应收票据及应收账款 | 215,954,567.78 | 242,173,281.19 | 278,460,634.08 | 277,427,812.53 |
| 其中：应收票据 | 42,858,534.82 | 51,395,137.63 | 65,840,948.26 | 71,225,887.8 |
| 应收账款 | 173,096,032.96 | 190,778,143.56 | 212,619,685.82 | 206,201,924.73 |
| 应收款项融资 | 24,582,055.02 | 16,525,395.15 | 66,994,488.18 | 56,386,377.46 |
| 预付款项 | 8,998,788.15 | 8,123,334.63 | 10,778,216.17 | 9,422,543.89 |
| 其他应收款合计 | 1,232,894.17 | 1,072,524.65 | 1,640,857.33 | 1,288,573.11 |
| 存货 | 420,415,267.14 | 393,658,902.3 | 372,176,041.96 | 354,463,939.1 |
| 其他流动资产 | 3,399,955.84 | 5,626,026.08 | 2,052,343.26 | 3,541,163.1 |
| 流动资产合计 | 1,157,811,911.26 | 1,187,757,203.7 | 1,210,057,294.76 | 1,234,632,290.67 |
| 非流动资产: | | | | |
| 长期股权投资 | 13,914,675.17 | 14,484,791.25 | 15,245,217.21 | 15,428,520.01 |
| 其他权益工具投资 | 5,621,494.45 | 5,621,494.45 | 5,621,494.45 | 5,621,494.45 |
| 投资性房地产 | 4,694,811.51 | 4,887,886.41 | 5,080,961.3 | 5,274,036.2 |
| 固定资产 | 1,026,735,802.29 | 1,018,950,316.72 | 978,505,722.58 | 998,982,296.26 |
| 在建工程 | 154,670,083.66 | 171,257,993.48 | 219,855,714.86 | 204,963,692.69 |
| 无形资产 | 137,647,929.21 | 139,317,412.36 | 141,282,179.18 | 143,264,655.1 |
| 长期待摊费用 | 2,386,461.97 | 2,587,517.85 | 2,819,505.45 | 2,903,080.77 |
| 递延所得税资产 | 15,335,688.83 | 14,292,932.13 | 13,396,990.19 | 13,015,247.06 |
| 其他非流动资产 | 25,021,233.13 | 17,213,845.85 | 309,702.54 | 834,243 |
| 非流动资产合计 | 1,386,028,180.22 | 1,388,614,190.5 | 1,382,117,487.76 | 1,390,287,265.54 |
| 资产总计 | 2,543,840,091.48 | 2,576,371,394.2 | 2,592,174,782.52 | 2,624,919,556.21 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 163,992,478.39 | 188,217,456.65 | 168,743,307.52 | 216,065,961.4 |
| 其中：应付票据 | 83,852,800 | 92,040,800 | 59,428,000 | 82,574,000 |
| 应付账款 | 80,139,678.39 | 96,176,656.65 | 109,315,307.52 | 133,491,961.4 |
| 合同负债 | 8,192,670.37 | 8,435,789.69 | 11,969,485.06 | 9,916,836 |
| 应付职工薪酬 | 11,301,493.88 | 12,568,806.26 | 12,217,578.89 | 12,767,822.38 |
| 应交税费 | 7,903,993.03 | 5,166,283.15 | 13,651,192.29 | 10,816,975.92 |
| 其他应付款合计 | 12,153,176.51 | 11,464,699.62 | 11,128,119.03 | 11,356,603.16 |
| 一年内到期的非流动负债 | 5,338,823.34 | 9,769,618.55 | 8,270,093.58 | 7,709,177.62 |
| 其他流动负债 | 27,265,214.55 | 35,928,839.64 | 43,260,479.2 | 55,138,706.72 |
| 流动负债合计 | 236,147,850.07 | 271,551,493.56 | 269,240,255.57 | 323,772,083.2 |
| 非流动负债: | | | | |
| 长期借款 | 43,300,000 | 63,840,000 | 76,073,833.34 | 36,050,000 |
| 应付债券 | 449,101,760.96 | 444,893,805.97 | 440,345,407.64 | 435,848,632.74 |
| 长期应付款 | 10,000,000 | 10,000,000 | 10,000,000 | 10,000,000 |
| 递延收益 | 51,881,591.81 | 46,145,575.32 | 47,224,157.2 | 48,506,660.87 |
| 递延所得税负债 | 36,218,333.59 | 34,235,227.01 | 30,964,081.81 | 31,318,912.71 |
| 非流动负债合计 | 590,501,686.36 | 599,114,608.3 | 604,607,479.99 | 561,724,206.32 |
| 负债合计 | 826,649,536.43 | 870,666,101.86 | 873,847,735.56 | 885,496,289.52 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 593,607,933 | 593,607,933 | 593,607,933 | 593,607,062 |
| 其他权益工具 | 25,098,497.28 | 25,098,497.28 | 25,098,497.28 | 25,098,817.24 |
| 资本公积 | 644,381,265.12 | 644,381,265.12 | 644,381,265.12 | 644,376,203.98 |
| 减:库存股 | 56,110,096 | 56,114,846.36 | 40,146,532.65 | - |
| 盈余公积 | 65,046,867.91 | 65,046,867.91 | 65,046,867.91 | 65,046,867.91 |
| 未分配利润 | 445,287,346.99 | 433,805,139.17 | 430,458,491.31 | 411,413,672.26 |
| 归属于母公司股东权益合计 | 1,717,311,814.3 | 1,705,824,856.12 | 1,718,446,521.97 | 1,739,542,623.39 |
| 少数股东权益 | -121,259.25 | -119,563.78 | -119,475.01 | -119,356.7 |
| 股东权益合计 | 1,717,190,555.05 | 1,705,705,292.34 | 1,718,327,046.96 | 1,739,423,266.69 |
| 负债和股东权益合计 | 2,543,840,091.48 | 2,576,371,394.2 | 2,592,174,782.52 | 2,624,919,556.21 |
| 公告日期 | 2025-10-29 | 2025-08-29 | 2025-04-24 | 2025-04-24 |
| 审计意见(境内) | | | | 标准无保留意见 |